Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2 N positive breast cancer patients. A population registry-based study in a European Country

World Journal of Surgery

Volumn 33, Issue 8, 2009, Pages 1659-1664

  Martinez Ramos, David ^a   Escrig Sos, Javier ^a   Alcalde Sanchez, Miguel ^a   Torrella Ramos, Ana ^b   Salvador Sanchis, Jose Luis ^a  

^a Castellon General Hospital   (Spain)

^b Direccion General de Salud Publica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE RECEPTOR; PROTEIN P53; TAMOXIFEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EUROPE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; METASTATIC LYMPH NODE RATIO; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PROGNOSIS; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SPAIN; SURVIVAL RATE;

EID: 68149125712     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0078-3     Document Type: Article

References (18)

1. L Caigang L Ping L Yang 2007 Clinical implications of metastatic lymph node ratio in gastric cancer BMC Cancer 7 200
2. H Chang-Ming L Bi-Juan L Hui-Shan 2008 Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus World J Gastroenterol 14 4383 4388
3. MB Slidell DC Chang JL Cameron 2008 Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis Ann Surg Oncol 15 165 174
4. MD Leggett SL Chen PD Schneider 2008 Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma Ann Surg Oncol 15 2493 2499
5. JK Chan DS Kapp MK Cheung 2007 The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients Br J Cancer 97 605 611
6. J Wang JM Hassett MT Dayton 2008 Lymph node ratio: role in the staging of node-positive colon cancer Ann Surg Oncol 15 1600 1608
7. B Kuru 2006 Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma EJSO 32 1082 1088
8. LJ Megale Costa HP Soares HA Gaspar 2004 Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer Am J Clin Oncol 27 304 306
9. PT Truong V Vinh-Hung G Cserni 2008 The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer Eur J Cancer 44 1670 1677
10. PT Truong E Berthelet J Lee 2005 The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes Cancer 103 2006 2014 (Pubitemid 40605106)
11. BCH Van der Wal RMJM Butzelaar S van der Meij 2002 Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer EJSO 28 481 489
12. V Vinh-Hung C Verschraegen DI Promish 2004 Ratios of involved nodes in early breast cancer Breast Cancer Res 6 R680 R688
13. M Voordeckers V Vinh-Hunga J Van de Steene 2004 The lymph node ratio as prognostic factor in node-positive breast cancer Radiother Oncol 70 225 230
14. Torrella-Ramos A, Martinez-Beneito MA, Alacreu-Garcia M et al (2005) Incidencia y supervivencia del cancer de mama femenino en la provincia de Castellon 1995-2002. Generalitat Valenciana. Conselleria de Sanitat, Valencia (Spain)
15. A Verdecchia S Francisci H Brenner 2007 Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data Lancet Oncol 8 784 796 (Pubitemid 47321601)
16. B Pestalozzi M Castiglione 2008 Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 19 Suppl 2 ii7 ii10
17. NCCN clinical practice guidelines in oncology breast cancer. http://www.nccn.org/professionals/physician-gls/PDF/breast.pdf
18. Greene FL, Page DL, Freming ID et al (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York